TWI683676B - Antimicrobial kit and article - Google Patents
Antimicrobial kit and article Download PDFInfo
- Publication number
- TWI683676B TWI683676B TW107147022A TW107147022A TWI683676B TW I683676 B TWI683676 B TW I683676B TW 107147022 A TW107147022 A TW 107147022A TW 107147022 A TW107147022 A TW 107147022A TW I683676 B TWI683676 B TW I683676B
- Authority
- TW
- Taiwan
- Prior art keywords
- antimicrobial
- fabric carrier
- antimicrobial agent
- fabric
- per square
- Prior art date
Links
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本發明是有關於一種抗微生物套組及用品,且特別是有關於一種具有抗微生物劑與織物載體的抗微生物套組及用品。 The invention relates to an antimicrobial kit and supplies, and in particular to an antimicrobial kit and supplies with an antimicrobial agent and a fabric carrier.
醫療感染是全球疾病管理的重大議題。手術部位感染,除了會造成醫療費用增加、住院天數延長之外,尚會升高病患發生敗血症及死亡的風險。「推動組合式照護措施降低手術部位感染先驅研究計畫」2016年研究報告指出,術前沐浴措施的執行率偏低。人體皮膚上固定存在著多種微生物,其為皮膚表面產生傷口時發生感染的主要來源。如果皮膚表面消毒不完全,皮膚表皮細胞層的微生物會經由醫療手術、侵入性醫療處置或傷口處理進入體內,造成醫療感染。因此,提高術前沐浴的執行率及加強術前皮膚準備,應為有效降低手術部位感染率的方式之一。 Medical infection is a major issue in global disease management. Infection at the surgical site, in addition to increasing medical costs and length of hospital stays, also increases the risk of sepsis and death. "The Pioneer Research Project to Promote Combined Care Measures to Reduce Surgical Site Infections" 2016 research report pointed out that the implementation rate of preoperative bathing measures is low. A variety of microorganisms are fixed on the human skin, which is the main source of infection when wounds are generated on the skin surface. If the disinfection of the skin surface is incomplete, the microorganisms in the skin epidermal cell layer will enter the body through medical surgery, invasive medical treatment or wound treatment, causing medical infections. Therefore, improving the execution rate of preoperative bathing and strengthening the preoperative skin preparation should be one of the ways to effectively reduce the infection rate at the surgical site.
近年來,隨著人口邁向高齡化,以及罹患特殊疾病例如愛滋病、尿毒症、創傷後遺症等而需要特殊護理或長期照護的病患越來越多,對於特殊護理或長期照護機構的感染控制要求升高,同時對機構內感染管制的執行作業亦有 越來越多的關注。特別是需要長期照護的年長者及病患身體較虛弱,於機構內發生皮膚接觸性傳染病和呼吸道傳染病「群聚感染」事件的風險較高,因此需加強機構內感染的監測、感染管制防護措施及照顧者知能相當重要。 In recent years, as the population is aging, and there are more and more patients who need special care or long-term care due to special diseases such as AIDS, uremia, and traumatic sequelae, infection control requirements for special care or long-term care institutions Increased, and the implementation of infection control within the organization More and more attention. In particular, the elderly and patients in need of long-term care are weak, and there is a higher risk of skin-contact infectious diseases and respiratory tract infectious diseases "group infection" incidents. Therefore, it is necessary to strengthen the monitoring and control of infections in the organization. Protective measures and caregiver awareness are very important.
此外,醫護人員在進行臨床醫療措施時,特別是緊急醫療措施,如在救護車上或急診內為患者皮膚進行消毒時,常直接將棉棒、紗布巾浸入消毒劑瓶罐內,再於皮膚表面進行擦拭消毒。然而,在緊急狀態下瓶罐操作起來較不便捷,且容易產生交叉感染,於完成消毒作業後餘下之消毒劑恐無法再次使用,也造成資源的浪費。 In addition, when medical personnel perform clinical medical measures, especially emergency medical measures, such as disinfecting the patient's skin in an ambulance or in an emergency department, they often directly dip cotton swabs and gauze towels into the disinfectant bottle and then on the skin Wipe the surface for disinfection. However, under emergency conditions, bottles and cans are less convenient to operate and are prone to cross-infection. The disinfectant remaining after the disinfection operation may not be used again, which also wastes resources.
有鑑於此,如何減少實施侵入性醫療處置後發生感染之風險、加強臨床醫療緊急措施以及長期照護機構內之感染管制,同時有效、適量且方便地使用消毒劑,現有技術實有待改善的必要。 In view of this, how to reduce the risk of infection after the implementation of invasive medical treatment, strengthen clinical emergency medical measures and infection control in long-term care institutions, and at the same time effectively, appropriately and conveniently use disinfectants, the existing technology needs to be improved.
為了解決先前技術中所述的問題,本揭示內容的目的在於提供一種抗微生物套組及一種抗微生物用品,以達成降低實施侵入性醫療處置後發生感染之風險、加強臨床醫療緊急措施以及長期照護機構內之感染管制,且方便使用者有效並適量使用抗微生物劑的效果。 In order to solve the problems described in the prior art, the purpose of the present disclosure is to provide an antimicrobial kit and an antimicrobial article to reduce the risk of infection after implementing invasive medical treatment, strengthen clinical emergency medical measures and long-term care Infection control within the organization, and it is convenient for users to effectively and appropriately use the effect of antimicrobial agents.
本揭示內容提供了一種抗微生物套組,包含抗微生物劑以及織物載體。抗微生物劑包含葡萄糖酸氯己定(chlorhexidine gluconate,CHG),織物載體每平方公分 可承載抗微生物劑0.025毫升至0.075毫升(mL/cm2),以局部給予(topical administration)皮膚每平方公分0.1至1.25毫克的葡萄糖酸氯己定,且織物載體不預先承載抗微生物劑。 The present disclosure provides an antimicrobial kit comprising an antimicrobial agent and a fabric carrier. The antimicrobial agent contains chlorhexidine gluconate (CHG), and the fabric carrier can carry the antimicrobial agent from 0.025 ml to 0.075 ml (mL/cm 2 ) per square centimeter, for topical administration of the skin 0.1 per square centimeter To 1.25 mg of chlorhexidine gluconate, and the fabric carrier does not carry antimicrobial agents in advance.
在一些實施方式中,抗微生物劑係重量體積百分比為0.1%至10%(w/v%)的葡萄糖酸氯己定水溶液。 In some embodiments, the antimicrobial agent is an aqueous solution of chlorhexidine gluconate from 0.1% to 10% (w/v%) by weight.
在一些實施方式中,抗微生物劑係包裝於一容器中,容器的材質包含,但不限於聚乙烯(polyethylene,PE)、聚對苯二甲酸乙二醇酯(Polyethylene Terephthalate,PET)或其組合。 In some embodiments, the antimicrobial agent is packaged in a container, and the material of the container includes, but is not limited to polyethylene (PE), polyethylene terephthalate (PET), or a combination thereof .
在一些實施方式中,織物載體具有多孔網狀結構。 In some embodiments, the fabric carrier has a porous network structure.
在一些實施方式中,織物載體的厚度為每平方公尺30克至100克(g/m2)。在一些實施例中,織物載體厚度為95g/m2。 In some embodiments, the thickness of the fabric carrier is 30 grams to 100 grams per square meter (g/m 2 ). In some embodiments, the thickness of the fabric carrier is 95 g/m 2 .
在一些實施方式中,織物載體係呈正方形或長方形。 In some embodiments, the fabric carrier is square or rectangular.
在一些實施方式中,其中織物載體係可將承載之抗微生物劑無殘留地釋出至皮膚上。 In some embodiments, the fabric carrier can release the carried antimicrobial agent onto the skin without residue.
在一些實施方式中,織物載體的材質包含,但不限於聚酯纖維、嫘縈或其組合。 In some embodiments, the material of the fabric carrier includes, but is not limited to polyester fiber, rayon, or a combination thereof.
在一些實施方式中,織物載體的材質為百分之百聚酯纖維,每平方公分可承載0.045至0.065毫升(mL/cm2)的抗微生物劑。 In some embodiments, the fabric carrier is made of 100% polyester fiber and can carry 0.045 to 0.065 milliliters (mL/cm 2 ) of antimicrobial agent per square centimeter.
本揭示內容另提供了一種抗微生物用品,包含織物載體,織物載體每平方公分承載0.025毫升至0.075毫升的抗微生物劑,抗微生物劑包含葡萄糖酸氯己定。其中,織物載體係用以局部給予皮膚每平方公分0.1至1.25毫克的葡萄糖酸氯己定。 The disclosure also provides an antimicrobial article comprising a fabric carrier, the fabric carrier carrying 0.025 ml to 0.075 ml of antimicrobial agent per square centimeter, the antimicrobial agent comprising chlorhexidine gluconate. Among them, the fabric carrier is used to locally administer 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter of skin.
在一些實施方式中,抗微生物用品係包裝於一容器中,容器的材質包含,但不限於聚乙烯、聚對苯二甲酸乙二醇酯或其組合。 In some embodiments, the antimicrobial product is packaged in a container, and the material of the container includes, but is not limited to, polyethylene, polyethylene terephthalate, or a combination thereof.
本揭示內容另提供了一種抗微生物用品,包含複數織物載體,各織物載體每平方公分承載0.025毫升至0.075毫升的抗微生物劑,抗微生物劑包含葡萄糖酸氯己定。其中,各織物載體係用以局部給予皮膚每平方公分0.1至1.25毫克的葡萄糖酸氯己定。 The disclosure also provides an antimicrobial article, comprising a plurality of fabric carriers, each fabric carrier carrying 0.025 ml to 0.075 ml of antimicrobial agent per square centimeter, the antimicrobial agent comprising chlorhexidine gluconate. Among them, each fabric carrier is used to locally administer 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter of skin.
在一些實施方式中,各織物載體承載30毫升的抗微生物劑,且抗微生物劑為重量體積百分比百分之2的葡萄糖酸氯己定水溶液。 In some embodiments, each fabric carrier carries 30 milliliters of antimicrobial agent, and the antimicrobial agent is an aqueous solution of chlorhexidine gluconate 2% by weight.
在一些實施方式中,這些織物載體的數量為8個,且包裝於一容器中,容器的材質為聚乙烯。 In some embodiments, the number of these fabric carriers is eight, and they are packed in a container, and the material of the container is polyethylene.
本揭示內容另提供了一種抗微生物用品,包含至少一織物載體,至少一織物載體每平方公分承載0.025毫升至0.075毫升的抗微生物劑,抗微生物劑包含葡萄糖酸氯己定,其中,至少一織物載體係用以局部給予皮膚每平方公分0.1至1.25毫克的葡萄糖酸氯己定。 The disclosure also provides an antimicrobial article comprising at least one fabric carrier, at least one fabric carrier carrying 0.025 ml to 0.075 ml of antimicrobial agent per square centimeter, the antimicrobial agent comprising chlorhexidine gluconate, wherein at least one fabric The carrier is for topical administration of 0.1 to 1.25 mg of chlorhexidine gluconate per square centimeter of skin.
在一些實施方式中,其中係將至少一織物載體 浸泡於抗微生物劑,使得浸泡後的至少一織物載體每平方公分承載0.025毫升至0.075毫升的抗微生物劑。 In some embodiments, at least one fabric carrier is attached Soaking in the antimicrobial agent, so that at least one fabric carrier after soaking carries 0.025 ml to 0.075 ml of antimicrobial agent per square centimeter.
在一些實施方式中,織物載體的材質為聚酯纖維,每平方公分承載0.045至0.065毫升的抗微生物劑。 In some embodiments, the fabric carrier is made of polyester fiber and carries 0.045 to 0.065 milliliters of antimicrobial agent per square centimeter.
在一些實施方式中,包含八個織物載體,八個織物載體係分別用於肩頸部位、胸部、雙臂至手掌、雙腿前側、下腹部、下頸部至後背、雙腿後側以及後腰間至臀部。 In some embodiments, eight fabric carriers are included, and the eight fabric carriers are used for shoulder and neck positions, chest, arms to palms, front sides of legs, lower abdomen, lower neck to back, back sides of legs, and From waist to hip.
在一些實施方式中,八個織物載體係用以依序用於肩頸部位、胸部、雙臂至手掌、雙腿前側、下腹部、下頸部至後背、雙腿後側以及後腰間至臀部。 In some embodiments, the eight fabric carriers are used in order for shoulder and neck positions, chest, arms to palms, front of legs, lower abdomen, lower neck to back, back of legs, and back waist To the buttocks.
在一些實施方式中,抗微生物用品係於實施侵入性醫療處置前使用。 In some embodiments, the antimicrobial article is used before performing an invasive medical treatment.
在一些實施方式中,係於實施侵入性醫療處置前先進行沐浴,再使用抗微生物用品。 In some embodiments, an antimicrobial article is used before bathing before performing an invasive medical treatment.
在一些實施方式中,抗微生物用品係於實施侵入性醫療處置當日及前三日每日使用一次。 In some embodiments, the antimicrobial article is used once daily on the day of the invasive medical treatment and the first three days.
在一些實施方式中,抗微生物用品係於實施侵入性醫療處置後每日使用至接受侵入性醫療處置處癒合。 In some embodiments, the antimicrobial article is used daily to heal where the invasive medical treatment is performed after the invasive medical treatment.
承上所述,本揭示內容之抗微生物套組及抗微生物用品皆包括含有葡萄糖酸氯己定之抗微生物劑以及織物載體。本揭示內容之抗微生物套組及抗微生物用品,由於織物載體可以擦拭的面積較大,故在使用上更加便利,且可適量使用抗微生物劑,同時仍能達到消毒的有效量。在一些實施例中,抗微生物套組或抗微生物用品包含八個織物載 體,可分別用於肩頸部位、胸部、雙臂至手掌、雙腿前側、下腹部、下頸部至後背、雙腿後側以及後腰間至臀部,避免交互汙染,落實消毒效果。若將抗微生物套組及抗微生物用品使用於接受侵入性醫療處置之病患,可降低實施侵入性醫療處置後發生感染之風險;若使用於特殊照護機構或長期照護機構內之患者,則可降低機構內感染的風險,以加強機構內之感染管制;若於施行臨床醫療措施時使用,則可方便使用者有效並適量使用抗微生物劑。 As mentioned above, the antimicrobial kits and antimicrobial supplies of the present disclosure all include antimicrobial agents containing chlorhexidine gluconate and fabric carriers. The anti-microbial kit and anti-microbial supplies of the present disclosure, because the fabric carrier can wipe a larger area, it is more convenient to use, and an appropriate amount of anti-microbial agent can be used while still achieving an effective amount of disinfection. In some embodiments, the antimicrobial kit or antimicrobial article contains eight fabric carriers The body can be used for shoulder, neck, chest, arms to palm, front of legs, lower abdomen, lower neck to back, back of legs, and back waist to buttocks, to avoid cross-contamination and implement disinfection effect. If the antimicrobial kit and antimicrobial supplies are used in patients undergoing invasive medical treatment, the risk of infection after invasive medical treatment can be reduced; if it is used in patients in special care institutions or long-term care institutions, it can be Reduce the risk of infection in the organization to strengthen the infection control in the organization; if it is used in the implementation of clinical medical measures, it can facilitate the user to effectively and appropriately use antimicrobial agents.
10‧‧‧肩頸部位 10‧‧‧ shoulder and neck
20‧‧‧胸部 20‧‧‧ chest
30‧‧‧雙臂至手掌 30‧‧‧ arms to palm
40‧‧‧雙腿前側 40‧‧‧front of legs
50‧‧‧下腹部 50‧‧‧ lower abdomen
60‧‧‧下頸部至後背 60‧‧‧ Lower neck to back
70‧‧‧雙腿後側 70‧‧‧Back of legs
80‧‧‧後腰間至臀部 80‧‧‧ from waist to hip
本發明上述和其他態樣、特徵及其他優點參照說明書內容並配合附加圖式得到更清楚的瞭解,其中:第1圖繪示本揭示內容之織物載體於人體正面皮膚擦拭區域的示意圖。 The above and other aspects, features and other advantages of the present invention can be more clearly understood with reference to the description and the accompanying drawings, in which: Figure 1 shows a schematic diagram of the fabric carrier of the present disclosure on the frontal skin wiping area of the human body.
第2圖繪示本揭示內容之織物載體於人體背面皮膚擦拭區域的示意圖。 FIG. 2 is a schematic diagram of the fabric carrier of the disclosure in the skin wiping area on the back of the human body.
為了使本揭示內容的敘述更加詳盡與完備,下文將參照附圖來描述本發明的實施方式與具體實施例;但這並非實施或運用本揭示內容具體實施例的唯一形式。以下所揭示的各實施例,在有益的情形下可相互組合或取代,也可在一實施例中附加其他的實施例,而無須進一步的記載或說明。 In order to make the description of the present disclosure more detailed and complete, the embodiments and specific embodiments of the present invention will be described below with reference to the drawings; however, this is not the only form for implementing or using specific embodiments of the present disclosure. The embodiments disclosed below can be combined or replaced with each other under beneficial circumstances, and other embodiments can be added to an embodiment without further description or description.
本文中所使用之「包含」、「包括」、「具有」及相似詞彙,指明其所記載的特徵、區域、整數、步驟、操作、元件與/或組件,但不排除其它的特徵、區域、整數、步驟、操作、元件、組件,與/或其中之群組。 The words "include", "include", "have" and similar words used in this article indicate the features, regions, integers, steps, operations, elements and/or components described therein, but do not exclude other features, regions, Integers, steps, operations, elements, components, and/or groups thereof.
本文中,術語「容器」在文中表示包含、但不限於固定形狀、非固定形狀,例如如袋體、罐體、瓶體或管體。 Herein, the term "container" is used herein to mean including, but not limited to, fixed shapes and non-fixed shapes, such as bags, cans, bottles or tubes.
本發明各種實施方式的抗微生物套組包含抗微生物劑與織物載體。抗微生物劑包含葡萄糖酸氯己定,可為重量體積百分比0.1%至10%(w/v)的葡萄糖酸氯己定水溶液,較佳為1.6%至2.4%(w/v)的葡萄糖酸氯己定水溶液,更佳為2%(w/v)的葡萄糖酸氯己定水溶液。 The antimicrobial kit of various embodiments of the present invention includes an antimicrobial agent and a fabric carrier. The antimicrobial agent comprises chlorhexidine gluconate, which may be an aqueous solution of chlorhexidine gluconate 0.1% to 10% (w/v) by weight, preferably 1.6% to 2.4% (w/v) chlorine gluconate The hexidine aqueous solution is more preferably a 2% (w/v) chlorhexidine gluconate aqueous solution.
織物載體具有多孔網狀結構,多孔網狀結構的孔隙可吸附抗微生物劑,藉以有效承載並攜帶抗微生物劑,且在使用時可將織物載體所承載的抗微生物劑完全釋出。以面積為600平方公分之織物載體為例,可承載15至45毫升之抗微生物劑,即每平方公分織物載體可承載抗微生物劑0.025毫升至0.075毫升,較佳為0.045毫升至0.065毫升,更佳為0.05毫升,以局部給予皮膚每平方公分0.1至1.25毫克的葡萄糖酸氯己定。織物載體的厚度為30g/m2至100g/m2,較佳為95g/m2。若織物載體所承載的葡萄糖酸氯己定水溶液低於0.025mL/cm2,釋放至皮膚表面的葡萄糖酸氯己定水溶液不足以達到消毒的效果;0.075mL/cm2則是織物載體所能承載的葡萄糖酸氯己定水溶液上限,超過上限 葡萄糖酸氯己定水溶液會滴落,增加操作難度。 The fabric carrier has a porous network structure, and the pores of the porous network structure can absorb the antimicrobial agent, thereby effectively carrying and carrying the antimicrobial agent, and the antimicrobial agent carried by the fabric carrier can be completely released during use. Taking a fabric carrier with an area of 600 square centimeters as an example, it can carry 15 to 45 milliliters of antimicrobial agent, that is, each square centimeter of fabric carrier can carry 0.025 milliliters to 0.075 milliliters of antimicrobial agent, preferably 0.045 milliliters to 0.065 milliliters. Preferably, it is 0.05 ml, and chlorhexidine gluconate 0.1 to 1.25 mg per square centimeter is applied topically to the skin. The thickness of the fabric carrier is 30 g/m 2 to 100 g/m 2 , preferably 95 g/m 2 . If the chlorhexidine gluconate aqueous solution carried by the fabric carrier is less than 0.025mL/cm 2 , the chlorhexidine gluconate aqueous solution released to the skin surface is not enough to achieve the disinfection effect; 0.075mL/cm 2 is the fabric carrier can carry The upper limit of the chlorhexidine gluconate aqueous solution exceeds the upper limit and the chlorhexidine gluconate aqueous solution will drip, increasing the difficulty of operation.
在一實施例中,織物載體之尺寸為20x30公分,可承載30毫升之抗微生物劑,其中抗生物劑為2%(w/v)之葡萄糖酸氯己定水溶液。依衛生福利部統計資料及體表面積計算公式:體表面積(平方公尺)=(體重(公斤)x身高(公分)/3600)1/2,可計算出2歲至成年國人之平均體表面積範圍為5812平方公分至18641平方公分。若以8片織物載體擦拭全身皮膚,可計算出每片承載有600毫克葡萄糖酸氯己定之織物載體可局部給予每平方公分皮膚0.25毫克至0.83毫克之抗微生物劑。 In one embodiment, the size of the fabric carrier is 20x30 cm and can carry 30 ml of antimicrobial agent, wherein the antimicrobial agent is 2% (w/v) chlorhexidine gluconate in water. According to the statistics of the Ministry of Health and Welfare and the calculation formula of body surface area: body surface area (square meters) = (weight (kg) x height (cm)/3600) 1/2 , the average body surface area range from 2 years old to adult Chinese can be calculated From 5812 square centimeters to 18641 square centimeters. If 8 pieces of fabric carrier are used to wipe the whole body skin, it can be calculated that the fabric carrier carrying 600 mg of chlorhexidine gluconate per tablet can be locally administered with 0.25 mg to 0.83 mg of antimicrobial agent per square centimeter of skin.
織物載體具有可將承載之抗微生物劑無殘留地釋出至皮膚上的特性。在一些實施例中,織物載體的材質為百分之百聚酯纖維(Polyester)的不織布。在一些實施例中,織物載體的材質可為聚酯纖維及嫘縈(Rayon)所組成之不織布,例如由百分之五十聚酯纖維及百分之五十嫘縈混紡而成的不織布。本發明不限制織物載體的形狀,織物載體較佳可為矩形,包含正方形、長方形等形狀。在一些實施例中,用於大面積擦拭時,織物載體可設計為長方形,例如20x30公分,正方形的織物載體於大面積擦拭消毒時易於捲曲不利擦拭,而長方形的織物載體於大面積擦拭消毒時有不易於捲曲且易於施力的優點。 The fabric carrier has the property of releasing the carried antimicrobial agent onto the skin without residue. In some embodiments, the material of the fabric carrier is a 100% polyester non-woven fabric. In some embodiments, the material of the fabric carrier may be a non-woven fabric composed of polyester fiber and Rayon, such as a non-woven fabric blended by fifty percent polyester fiber and fifty percent Rayon. The present invention does not limit the shape of the fabric carrier. The fabric carrier may preferably be rectangular, including square, rectangular and other shapes. In some embodiments, when used for large-area wiping, the fabric carrier may be designed to be rectangular, for example, 20x30 cm. A square-shaped fabric carrier is liable to curl when wiped and disinfected in a large area, and is unfavorable for wiping, while a rectangular fabric carrier is wiped and disinfected in a large area. It has the advantages of not easy to curl and easy to apply force.
本發明的織物載體具多孔網狀結構與厚度,可於臨床擦拭時保護皮膚不遭受過度物理性摩擦傷害。因此,在一較佳的實施例中,抗微生物套組中的抗微生物劑為 2%(w/v)葡萄糖酸氯己定水溶液,且抗微生物劑可以在無保濕潤膚成分下亦能維持舒適膚觸。 The fabric carrier of the present invention has a porous network structure and thickness, which can protect the skin from excessive physical friction damage during clinical wiping. Therefore, in a preferred embodiment, the antimicrobial agent in the antimicrobial kit is 2% (w/v) chlorhexidine gluconate aqueous solution, and antimicrobial agent can maintain comfortable skin touch without moisturizing emollient ingredients.
抗微生物套組為組合式產品,織物載體與抗微生物劑分別在個別的分隔區內,並在相同或不同的包裝中,使用時再將織物載體與抗微生物劑進行混和。抗微生物套組中織物載體的數量可以是一片織物載體、或是複數片織物載體。抗微生物套組中的抗微生物劑可容置於瓶體內,瓶體可選擇不會與葡萄糖酸氯己定反應發生沉澱現象的材質,而不會影響抗微生物劑的功效。前述材質可例如為聚乙烯(polyethylene,PE)、聚對苯二甲酸乙二醇酯(Polyethylene Terephthalate,PET)或其組合。其中,聚乙烯可包含高密度聚乙烯及低密度聚乙烯。在一具體實施例中,抗微生物套組可包含容置於瓶體中之2%(w/v)葡萄糖酸氯己定水溶液以及容置於袋體之織物載體。使用時,將葡萄糖酸氯己定水溶液全部倒入袋體中,使織物載體浸潤於葡萄糖酸氯己定水溶液中,待織物載體承載足量的葡萄糖酸氯己定水溶液後再取出使用。 The antimicrobial kit is a combined product. The fabric carrier and the antimicrobial agent are in separate compartments and in the same or different packaging. When used, the fabric carrier and the antimicrobial agent are mixed. The number of fabric carriers in the antimicrobial kit may be one fabric carrier or a plurality of fabric carriers. The antimicrobial agent in the antimicrobial kit can be contained in the bottle body, and the bottle body can be selected from materials that will not react with chlorhexidine gluconate to cause precipitation, without affecting the effectiveness of the antimicrobial agent. The aforementioned material may be, for example, polyethylene (PE), polyethylene terephthalate (PET), or a combination thereof. Among them, polyethylene may include high-density polyethylene and low-density polyethylene. In a specific embodiment, the antimicrobial kit may include a 2% (w/v) chlorhexidine gluconate aqueous solution contained in the bottle and a fabric carrier contained in the bag. When in use, all the chlorhexidine gluconate aqueous solution is poured into the bag body, so that the fabric carrier is infiltrated in the chlorhexidine gluconate aqueous solution, and the fabric carrier carries a sufficient amount of chlorhexidine gluconate aqueous solution before taking it out for use.
抗微生物用品包含抗微生物劑與織物載體,且為預先結合式產品,即織物載體預先承載抗微生物劑。其中抗微生物劑及織物載體與前述抗微生物套組之抗微生物劑及織物載體相同,於此不再贅述。 The antimicrobial article contains an antimicrobial agent and a fabric carrier, and is a pre-bonded product, that is, the fabric carrier carries an antimicrobial agent in advance. The antimicrobial agent and the fabric carrier are the same as the antimicrobial agent and the fabric carrier of the aforementioned antimicrobial kit, which will not be repeated here.
在一具體實施例中,抗微生物用品的製作過程係先將20%(w/v)葡萄糖酸氯己定水溶液加入純水稀釋至2%(w/v),然後將2%(w/v)葡萄糖酸氯己定水溶液倒入裝有 至少一片不織布的袋體內,較佳為8片不織布,封口後即獲得抗微生物用品。其中,袋體的材質為聚乙烯,聚乙烯袋體除了密封性佳之外,與抗微生物劑長時間接觸下不會與葡萄糖酸氯己定作用而使抗微生物劑發生沉澱,不影響抗微生物劑的功效。 In a specific embodiment, the manufacturing process of the antimicrobial article is to first dilute the 20% (w/v) chlorhexidine gluconate aqueous solution to pure water to 2% (w/v), and then 2% (w/v) ) The chlorhexidine gluconate aqueous solution is poured into At least one piece of nonwoven fabric is preferably 8 pieces of nonwoven fabric, and the antimicrobial article is obtained after sealing. Among them, the material of the bag body is polyethylene. In addition to the good sealing performance, the polyethylene bag body will not interact with chlorhexidine gluconate under long-term contact with the antimicrobial agent and cause the antimicrobial agent to precipitate, and does not affect the antimicrobial agent. Effect.
在一些實施例中,抗微生物套組或抗微生物用品可在實施侵入性醫療處置前施用於皮膚,以降低醫療感染風險。侵入性醫療處置可例如為:劃刀切開手術、穿刺、插入導管或引流管等等。以劃刀切開手術為例:患者於手術前三日至前一晚全身沐浴後,每日從抗微生物套組或抗微生物用品中取出以2%(w/v)葡萄糖酸氯己定水溶液充分浸潤的織物載體擦拭全身;手術當天再次以抗微生物套組或抗微生物用品擦拭全身。侵入性醫療處置後,亦可以抗微生物套組或抗微生物用品擦拭全身或接受侵入性醫療處置處,直至接受侵入性醫療處置處癒合。 In some embodiments, an antimicrobial kit or antimicrobial article can be applied to the skin before performing an invasive medical treatment to reduce the risk of medical infections. The invasive medical treatment may be, for example, scalpel incision operation, puncture, insertion of catheter or drainage tube, and so on. Take the scalpel incision operation as an example: the patient takes a full body bath three days before the operation to the night before, and removes from the antimicrobial kit or antimicrobial supplies daily with 2% (w/v) chlorhexidine gluconate aqueous solution Wipe the whole body with the infiltrated fabric carrier; wipe the whole body again with antimicrobial kit or antimicrobial supplies on the day of surgery. After the invasive medical treatment, the antimicrobial kit or antimicrobial supplies can also be used to wipe the whole body or receive the invasive medical treatment until the invasive medical treatment is healed.
在一實施例中,抗微生物套組或抗微生物用品可用於皮膚或器具的清潔及消毒,使用後無需再以水清洗。例如:加護病房的病患、長期照護的病患可每日以抗微生物套組或抗微生物用品擦拭全身,以降低院內感染之風險;接受侵入性醫療處置後之患者,也可以抗微生物套組或抗微生物用品擦拭全身或接受侵入性醫療處置之患部,以降低術後感染的風險;於進行臨床醫療時,尤其是緊急狀態下,例如在救護車上緊急以抗微生物套組或抗微生物用品用於患者皮膚的消毒,藉由一包裝具有多片含2%(w/v)葡萄糖酸氯己 定水溶液浸漬的織物載體的組合,以達到使用方便、避免浪費抗微生物劑的效果;醫療器材如導管在實施侵入性醫療處置前,亦可以抗微生物套組或抗微生物用品進行消毒。 In one embodiment, the anti-microbial kit or anti-microbial article can be used for cleaning and disinfecting skin or utensils, and no need to wash with water after use. For example, patients in the intensive care unit and long-term care can wipe the whole body with antimicrobial kits or antimicrobial supplies daily to reduce the risk of nosocomial infection; patients after receiving invasive medical treatment can also use antimicrobial kits Or antimicrobial supplies to wipe the whole body or the affected area undergoing invasive medical treatment to reduce the risk of postoperative infection; during clinical treatment, especially in an emergency, such as emergency use of antimicrobial kits or antimicrobial supplies in ambulances For the disinfection of the patient's skin, with a package of multiple tablets containing 2% (w/v) chlorohexyl gluconate The combination of fabric carrier impregnated with a fixed aqueous solution to achieve the effect of convenient use and avoid wasting antimicrobial agents; medical equipment such as catheters can also be disinfected with antimicrobial kits or antimicrobial supplies before invasive medical treatment.
在一實施例中,抗微生物套組或抗微生物用品於使用時,係以承載有抗微生物劑之織物載體局部施予皮膚以消毒殺菌,且單張織物載體係分區單次使用以預防交互感染。例如:依據人體所需的消毒部位建立八步驟臨床使用次序,按照此次序擦拭可避免交互感染,依照第1圖及第2圖將身體分為八區,分別為人體正面的肩頸部位10、胸部20、雙臂至手掌30、雙腿前側40、下腹部50,人體背面的下頸部至後背60、雙腿後側70、後腰間至臀部80。其中,胸部20更可包含胸部及胸部周邊部位,後腰間至臀部80包含腰間至雙臀與大腿連接處之後側。使用抗微生物套組或抗微生物用品時,依上述八個分區每區分別使用一片承載有抗微生物劑之織物載體擦拭需要清潔消毒的皮膚,並確保肌膚充分擦拭到抗微生物劑,待30秒鐘使肌膚自然乾燥即可。以微生物劑擦拭過後,肌膚會呈現光澤感,可依此判斷肌膚已充分擦拭到抗微生物劑。在其他實施例中,抗微生物套組或抗微生物用品於使用時,也可單次使用單張承載有抗微生物劑之織物載體以施用於局部皮膚,並不限制於上述用法。
In one embodiment, when the antimicrobial kit or antimicrobial article is used, the fabric carrier carrying the antimicrobial agent is applied locally to the skin for disinfection and sterilization, and the single fabric carrier is used in a single partition to prevent cross infection . For example: establish an eight-step clinical use sequence according to the disinfection site required by the human body, wipe in this order to avoid cross infection, and divide the body into eight areas according to Figure 1 and Figure 2, which are the shoulder and neck positions on the front of the
承上所述,本揭示內容之抗微生物套組及抗微生物用品皆包括含有葡萄糖酸氯己定之抗微生物劑以及織物載體。本揭示內容之抗微生物套組及抗微生物用品,由於織物載體可以擦拭的面積較大,故在使用上更加便利,且可 適量使用抗微生物劑,同時仍能達到消毒的有效量。在一些實施例中,抗微生物套組或抗微生物用品包含八個織物載體,可分別用於肩頸部位、胸部、雙臂至手掌、雙腿前側、下腹部、下頸部至後背、雙腿後側以及後腰間至臀部,避免交互汙染,落實消毒效果。若將抗微生物套組及抗微生物用品使用於接受侵入性醫療處置之病患,可降低實施侵入性醫療處置後發生感染之風險;若使用於特殊照護機構或長期照護機構內之患者,則可降低機構內感染的風險,以加強機構內之感染管制;若於施行臨床醫療措施時使用,則可方便使用者有效並適量使用抗微生物劑。 As mentioned above, the antimicrobial kits and antimicrobial supplies of the present disclosure all include antimicrobial agents containing chlorhexidine gluconate and fabric carriers. The anti-microbial kits and anti-microbial articles of the present disclosure are more convenient to use because of the larger area that the fabric carrier can wipe. Appropriate use of antimicrobial agents while still achieving an effective amount of disinfection. In some embodiments, the antimicrobial kit or antimicrobial article includes eight fabric carriers, which can be used for shoulder and neck positions, chest, arms to palms, front legs, lower abdomen, lower neck to back, double The back side of the legs and the back waist to the buttocks, to avoid cross-contamination, and implement the disinfection effect. If the antimicrobial kit and antimicrobial supplies are used in patients undergoing invasive medical treatment, the risk of infection after invasive medical treatment can be reduced; if it is used in patients in special care institutions or long-term care institutions, it can be Reduce the risk of infection in the organization to strengthen the infection control in the organization; if used in the implementation of clinical medical measures, it can facilitate the user to effectively and appropriately use antimicrobial agents.
雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明的精神和範圍內,當可作各種的更動與潤飾,因此本發明的保護範圍當視後附的申請專利範圍所界定者為準。 Although the present invention has been disclosed as above in the embodiments, it is not intended to limit the present invention. Any person who is familiar with this art can make various changes and modifications within the spirit and scope of the present invention, so the protection of the present invention The scope shall be determined by the scope of the attached patent application.
10‧‧‧肩頸部位 10‧‧‧ shoulder and neck
20‧‧‧胸部 20‧‧‧ chest
30‧‧‧雙臂至手掌 30‧‧‧ arms to palm
40‧‧‧雙腿前側 40‧‧‧front of legs
50‧‧‧下腹部 50‧‧‧ lower abdomen
Claims (24)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107147022A TWI683676B (en) | 2018-12-25 | 2018-12-25 | Antimicrobial kit and article |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW107147022A TWI683676B (en) | 2018-12-25 | 2018-12-25 | Antimicrobial kit and article |
Publications (2)
Publication Number | Publication Date |
---|---|
TWI683676B true TWI683676B (en) | 2020-02-01 |
TW202023634A TW202023634A (en) | 2020-07-01 |
Family
ID=70413580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW107147022A TWI683676B (en) | 2018-12-25 | 2018-12-25 | Antimicrobial kit and article |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI683676B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200602097A (en) * | 2004-04-08 | 2006-01-16 | 3M Innovative Properties Co | Skin antiseptic composition dispenser and methods of use |
WO2006062740A2 (en) * | 2004-11-22 | 2006-06-15 | Nu-Tein Co., Inc. | Topical skin patch containing xanthophylls |
US7427574B2 (en) * | 2005-08-19 | 2008-09-23 | Sage Products, Inc. | Non-woven wash cloth |
CN204016150U (en) * | 2014-01-21 | 2014-12-17 | 钟励 | A kind of 2% chlorhexidine gluconate antibacterial wet tissue |
CN104622716A (en) * | 2015-02-27 | 2015-05-20 | 李航 | Medical nursing wet tissue which is non-alcoholic, long-acting, antibacterial and capable of removing dirt and disinfectant |
-
2018
- 2018-12-25 TW TW107147022A patent/TWI683676B/en active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200602097A (en) * | 2004-04-08 | 2006-01-16 | 3M Innovative Properties Co | Skin antiseptic composition dispenser and methods of use |
WO2006062740A2 (en) * | 2004-11-22 | 2006-06-15 | Nu-Tein Co., Inc. | Topical skin patch containing xanthophylls |
US7427574B2 (en) * | 2005-08-19 | 2008-09-23 | Sage Products, Inc. | Non-woven wash cloth |
CN204016150U (en) * | 2014-01-21 | 2014-12-17 | 钟励 | A kind of 2% chlorhexidine gluconate antibacterial wet tissue |
CN104622716A (en) * | 2015-02-27 | 2015-05-20 | 李航 | Medical nursing wet tissue which is non-alcoholic, long-acting, antibacterial and capable of removing dirt and disinfectant |
Also Published As
Publication number | Publication date |
---|---|
TW202023634A (en) | 2020-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101725175B1 (en) | Antimicrobial composition | |
EP2811988B1 (en) | Adhesive patch with antimicrobial composition | |
AU2018271354A1 (en) | Materials and methods for controlling infections | |
CN103340816B (en) | Special private care wet tissue for women | |
JP2018521992A (en) | Ways to improve health outcomes | |
CN101810639A (en) | Broad-spectrum touch-out medical bactericide and preparation method thereof | |
TWI683676B (en) | Antimicrobial kit and article | |
TWI735998B (en) | Antimicrobial kit and article | |
Borgatta et al. | Hand protection and protection from hands: hand-washing, germicides and gloves | |
CN202207210U (en) | Medical combined package with disposable hand sterilization non-woven wet tissues | |
WO2011056486A2 (en) | Devices, methods, and composition for controlling infections | |
RU72626U1 (en) | UNIVERSAL LAYING FOR THE ELIMINATION OF ACCIDENTS WHEN WORKING WITH ACTIVATORS OF DANGEROUS INFECTIOUS DISEASES | |
CN111358769A (en) | Antimicrobial kits and articles | |
CN1644145A (en) | Wet nonwoven towel containing tannic acid | |
CN205031578U (en) | Cartridge bag is gargled in containing of treatment oral cavity fungal infection | |
CN205433906U (en) | Disposable package of changing dressings | |
CN209091978U (en) | Single-use skin nursing medical treatment packet | |
CN208339919U (en) | A kind of disposable wound cleaning towel | |
CN202190893U (en) | Disposable protective sleeve for hair washing basin | |
CN202426671U (en) | Disposable dressing-changing packet | |
Romoşan et al. | Professional and management issues in the survey and control of nosocomial infections in general surgery hospitals. | |
Wickramasinghe et al. | Health care associated infection (HCAI) | |
Penwick | Preoperative patient preparation | |
Pope | Pope's manual of nursing procedure | |
CN202821652U (en) | Portable type multifunctional skin disinfection bag |